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Erythrosine (ErB) is a xanthene and an US Food and Drug Administration approved dye used in foods,
drugs and cosmetics. Although its utilization is permitted, ErB is described as inhibitor of enzymes and
protein–protein interactions and is toxic to pituitary and spermatogenesis processes. However, the geno-
toxicity and mutagenicity of ErB is inconclusive in the literature. This study aimed to analyze the geno-
toxicity of this dye using the alkaline comet assay and is the ﬁrst investigation to evaluate ErB
mutagenicity using the cytokinesis block micronucleus cytome (CBMN-Cyt) assay in HepG2 cells. These
cells were chosen because they produce phase I and phase II enzymes that can mimic in vivometabolism.
The cells were treated with seven concentrations (0.1–70.0 lg mL1) of ErB, and the results showed geno-
toxicity at the two highest concentrations and mutagenicity at six concentrations. Furthermore, as micro-
nuclei result from clastogenic and aneugenic processes, while comet assay is often considered more
sensitive and detects DNA single strain breaks, we suggest that an aneugenic is responsible for the
observed damage. Although ErB is approved for use in the food, cosmetic and pharmaceutical industries,
it must be used carefully because it damages the DNA structure.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
The use of color additives dates from 5000 B.C. by the Ancient
Egyptians, and historians estimate that colored food emerged by
1500 B.C. Currently, the food industry considers color as an impor-
tant criterion for food choice, thus synthetic colorants are fre-
quently used to improve the esthetic quality (Mpountoukas et al.,
2010). The literature data estimates the production of colorants
to be 8,000,000 tons annually (Revankar and Lele, 2007).
The use of these artiﬁcial colorants would be safe if their con-
sumption was below the ADI (Acceptable Daily Intake) limit. How-
ever, when consuming high amounts of these colored products,
people may be exposed to high concentrations of these chemical
compounds, especially children due to their low body weights
compared to adults (Dixit et al., 2011).BMN-Cyt, cytokinesis block
iﬁed Eagle medium; DMSO,
nd Drug Administration; FBS,
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x: +55 16 3602 4725.
hequer).
sevier OA license.Among the synthetic food dyes, erythrosine B (ErB, 20,40,50,70-
tetraiodoﬂuorescein) is a cherry-pink food colorant with a poly-
iodinated xanthene structure; it is unique in this class approved
by the US Food and Drug Administration (FDA) and is widely used
in foods, drugs and cosmetics (Ganesan et al., 2011; Mpountoukas
et al., 2010; Silbergeld and Anderson, 1982). Although its utiliza-
tion is permitted, ErB has been described as having an inﬂuence
on childhood behavior (Silbergeld and Anderson, 1982) and inter-
fering with thyroid function due to the high iodine content (Bora
et al., 1969; Jennings et al., 1990b). In vitro models showed the
inhibition of drug-metabolizing enzymes (Mizutani, 2009), potent
inhibition of two protein–protein interactions involving the tumor
necrosis factor (TNF) superfamily (Ganesan et al., 2011) and both
high cytotoxicity and cytostaticity (Mpountoukas et al., 2010).
However, there are conﬂicting results with regard to genotoxi-
city and mutagenicity. Both negative (Auletta et al., 1977; Brown
et al., 1978) and positive (Matula and Downie, 1984) results were
obtained in bacterial reversion assays, and Lakdawalla and Netraw-
ali (1988b) and Lin and Brusick (1986) describe negative results
using the Ames test. Therefore, the goal of the present study was
to evaluate the genotoxicity and mutagenicity of ErB in vitro using
the comet assay and cytokinesis-block micronucleus cytome
(CBMN-Cyt) assay. We used HepG2 cells because this cell line pro-
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false-positive events (Kirsch-Volders et al., 2011).2. Materials and methods
2.1. Chemical compounds and concentration selection
Erythrosine B (ErB; CAS, 15905-32-5; CI, 45430; P95% purity; Fig. 1), trypan
blue (CAS: 72-57-1), cytochalasin B (CAS: 14930-96-2) and acridine orange (CAS:
10127-02-3) were purchased from Sigma–Aldrich (St. Louis, MO, USA). Doxorubicin
(CAS: 23214-92-8) was purchased from Laboratório Bérgamo (Taboão da Serra, Bra-
zil). Dimethylsulfoxide (DMSO, CAS: 67-68-5) was purchased from Merck (Darms-
tadt, Germany). Dulbecco’s Modiﬁed Eagle Medium (DMEM), fetal bovine serum
(FBS) and the penicillin–streptomycin mix were purchased from Gibco (Carlsbad,
CA, USA). Normal melting point and low melting point agaroses (CAS: 9012-36-6)
were obtained from Invitrogen (Carlsbad, CA, USA), and GelRed™ (CAS: 7732-18-
5) was purchased from Biotium (Hayward, CA, USA). All other chemicals were ana-
lytical grade products with the highest purity available.
The erythrosine B and doxorubicin concentrations were selected using trypan
blue dye exclusion at the moment of the harvest. The highest concentration at
which cell viability was P80% was identiﬁed, and the other concentrations were
based on this concentration.
Erythrosine B and doxorubicin were dissolved in DMSO at 50 mg mL1 and
phosphate buffer solution (PBS, pH 7.4) at 7 mg mL1, respectively, just before
use. The highest DMSO concentration applied to the cell cultures was 0.7%.
2.2. Cell line
A human derived liver cell line (HepG2, HB-8065, hepatocellular carcinoma)
was obtained from American Type Culture Collection (ATCC, Rockville, MD, USA)
and cultured in DMEM containing 10% heat-inactivated FBS and 1% antibiotic mix
(penicillin/streptomycin). The cells were maintained at 37 C in a humidiﬁed atmo-
sphere of 5% CO2 and 95% air in an incubator (Forma Series II, Thermo Electron Cor-
poration, USA).
2.3. Comet assay
The alkaline single-cell gel electrophoresis assay (comet assay) was performed
according to Singh et al. (1988) and Tice et al. (2000), with minor modiﬁcations.
Brieﬂy, 2  105 HepG2 cells were seeded in a 24-well plate for 24 h. The cells were
then treated with erythrosine B at 0.1, 0.2, 2.0, 10.0, 25.0, 50.0 or 70.0 lg mL1 (ﬁnal
concentration) for 4 h; vehicle control (0.7% DMSO) and positive control (doxorubi-
cin 0.3 lg mL1) treatments were also performed. The HepG2 cell suspension was
mixed with 37 C low-melting point agarose and transferred to normal-melting
point agarose-coated slides. The slides were then covered with a cover slip and
incubated at 4 C for 20 min for agarose solidiﬁcation. The cover slips were re-
moved, and cells were incubated in lysis solution (2.5 M NaCl, 100 mM EDTA,
10 mM Tris, 10% DMSO and 1% Triton X-100) overnight at 4 C. The slides were then
incubated in electrophoresis solution (300 mM NaOH and 1 mM EDTA) for 40 min
at 4 C and then transferred to a horizontal electrophoresis unit containing the
same solution. The electrophoresis conditions were 25 V (0.78 V/cm) and 300 mA
for 20 min at 4 C. Lastly, the slides were washed in a neutralization buffer (0.4 M
Tris) for 20 min at 4 C and ﬁxed in ethanol for 5 min. Immediately before the anal-
ysis, the slides were stained with Gel Red (1:10,000) and scored using a ﬂuores-
cence microscope (Axiostar, Zeiss, Germany) equipped with a 515–560 nm
excitation ﬁlter, a 590 nm barrier ﬁlter and an integrated digital camera. The Tail
Moment (product of the proportion of the tail’s intensity and the displacement of
the tail’s center of mass relative to the center of the head) and Tail Intensity (%
DNA in the tail) were evaluated using Comet Assay IV software (Perceptive Instru-Fig. 1. Chemical structure of ErB.ments, Suffolk, UK) at 400 magniﬁcation. One hundred randomly chosen nucle-
oids were analyzed per treatment, and a total of three independent experiments
were performed.
2.4. Cytokinesis-block micronucleus cytome (CBMN-Cyt) assay
The mutagenicity was evaluated as described by Fenech (2007), and the culture
protocol followed Natarajan and Darroudi (1991), with modiﬁcations. A total of
5  105 HepG2 cells were incubated in 25 cm2 culture ﬂasks for 24 h and then trea-
ted with 0.1, 0.2, 2.0, 10.0, 25.0, 50.0 or 70.0 lg mL1 erythrosine B (ﬁnal concentra-
tion) or 0.03 lg mL1 doxorubicin. After 20 h of treatment (44 h after the initiation
of the culture), the cells were washed with PBS, the culture media was changed, and
cytochalasin B (ﬁnal concentration of 3.0 lg mL1) was added. The cells were then
incubated for an additional 28 h, harvested, treated with cold hypotonic solution
(1% sodium citrate) and ﬁxed with formaldehyde and methanol–acetic acid (3:1).
The slides were stained immediately before analysis using 40 lg mL1 acridine or-
ange, and the binucleated cells with 1–4 micronuclei (MNi) were scored at 1000
magniﬁcation. Additionally, the frequency of nucleoplasmic bridges (NPBs) and nu-
clear buds (NBUDs) were evaluated using the criteria of Fenech (2007). The Nuclear
Division Index (NDI) was also calculated to evaluate the altered mitotic activity
and/or cytostatic effects according to the following formula (Eastmond and Tucker,
1989): NDI = (M1 + 2M2 + 3M3 + 4M4)/N, whereM1,M2,M3 andM4 are the number of
cells with one, two, three and four nuclei and N is the number of cells assayed.
A total of 500 cells per treatment were analyzed for the NDI calculation and
1000 binucleated cells for the MNi, NPBs and NBUDs frequencies. A total of three
independent experiments were performed.
2.5. Statistical analysis
The data are expressed as the mean ± SD of three independent experiments. The
results were analyzed using a one-way ANOVA and post hoc Dunnett’s test and were
considered signiﬁcantly different if the p values were 0.05 or less.
3. Results
The results of the genotoxic evaluation of erythrosine B are pre-
sented in Figs. 2 and 3.
The sensitivity of the in vitro assay system is demonstrated by
comparing the positive control group (0.3 lg mL1 doxorubicin)
to the vehicle control group (0.7% DMSO), displaying signiﬁcant in-
creases in both the Tail Moment and Tail Intensity. Only the two
highest concentrations of ErB tested (50.0 and 70.0 lg mL1) were
signiﬁcantly different (p < 0.05) from the vehicle control group
when the Tail Moment and Tail Intensity, which represent the ex-
tent of DNA damage, were analyzed.
For all of the tested concentrations, the cell viability using the
trypan-blue exclusion method showed P80% viability.
Using the micronucleus assay, at least 35% binucleated cells
were observed after all of the treatments, indicating a single divi-
sion cycle after the addition of cytochalasin B. The CBMN-Cyt re-
sults (Table 1) showed increased MNi frequencies at six of the
seven ErB concentrations (0.2–70.0 lg mL1) when compared to
vehicle control group. The difference of MNi frequencies between
the vehicle and positive control groups demonstrates the efﬁciency
of the assay. Furthermore, as shown in Table 1, the low NPBs and
NBUDs frequencies were not signiﬁcantly different from the vehi-
cle control group. The cytokinesis-block micronucleus cytome as-
say also evaluates the Nuclear Division Index (NDI), which was
similar for all of the control and experimental groups.
4. Discussion
Comet assay and CBMN-Cyt are often combined to evaluate the
genotoxicity and mutagenicity of chemical compounds, including
dyes and pigments, in vitro (An et al., 2007; Oliveira et al., 2010;
Tsuboy et al., 2007). This association provides the analysis of two
steps of DNA damage: the comet assay detects genomic lesions
that can be repaired (Gontijo et al., 2003), whereas CBMN-Cyt is
a useful tool to evaluate the chromosomal aberrations that can
be caused by genetic defects and/or exogenous endotoxins, in addi-
tion to being an early biomarker for carcinogenesis (Bonassi et al.,
Fig. 2. Photomicrographs of GelRed-stained comet assay. (A) Untreated HepG2 cell, (B) 0.3 lg mL1 doxorubicin-treated HepG2 cell and (C) 70.0 lg mL1 ErB-treated HepG2
cell.
Fig. 3. Genotoxic effect on the Tail Intensity (A) and Tail Moment (B) of HepG2 cells treated with 0.1, 0.2, 2.0, 10.0, 25.0, 50.0 and 70.0 lg mL1 erythrosine (ErB) for 4 h. n = 3.
Values are the mean ± SD; Vehicle Control, 0.7% dimethylsulfoxide; positive control, 0.3 lg mL1 doxorubicin. ⁄Signiﬁcantly different from the vehicle control group (p < 0.05).
Table 1
Cytokinesis-block micronucleus cytome (CBMN-Cyt) assay of HepG2 cells treated
with erythrosine (ErB) and the respective controls.
Treatment (lg mL1) Total No. in 1000 BN cells NDI
MNi NPBs NBUDs
Vehicle control 19 ± 3 4 ± 2 2 ± 2 1.6 ± 0.1
Positive control 99 ± 14* 16 ± 5 10 ± 7 1.6 ± 0.1
0.1 ErB 44 ± 18 5 ± 2 3 ± 2 1.7 ± 0.2
0.2 ErB 48 ± 13* 6 ± 2 1 ± 1 1.6 ± 0.2
2.0 ErB 50 ± 3* 4 ± 2 2 ± 2 1.6 ± 0.1
10.0 ErB 49 ± 5* 6 ± 3 2 ± 0 1.7 ± 0.1
25.0 ErB 54 ± 9* 5 ± 3 3 ± 4 1.6 ± 0.1
50.0 ErB 60 ± 7* 8 ± 5 4 ± 3 1.7 ± 0.2
70.0 ErB 81 ± 16* 6 ± 2 6 ± 4 1.7 ± 0.2
Values are the mean ± SD; BN, binucleated cell; MNi, micronuclei; NPBs, nucleo-
plasmic bridges; NBUDs, nuclear buds; NDI, nuclear division index; n = 3. Vehicle
control, 0.7% dimethylsulfoxide; Positive control, 0.03 lg mL1 doxorubicin.
* Signiﬁcantly different from the control group (p < 0.05).
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cells are frequently used to evaluate genotoxins (Chequer et al.,
2009; Ferraz et al., 2011) due to their capacity to produce phase I
and phase II metabolic enzymes that can potentialize or inactivate
chemical compounds, closely mimicking in vivo biotransformation
(Knasmuller et al., 2004; Tsuboy et al., 2007).
ErB is an unique, FDA-approved xanthene dye that is widely
used in foods, cosmetics and pharmaceuticals. In USA, ErB is al-
lowed for current use, and is usually used in sweets and foods mar-
keted to children such as popsicles, cake frosting and another
sweetmeats. Concerns about the safety of this dye were raised by
FDA following the publication of a report indicating that, under
experimental conditions, ErB at high dose levels (4% in the diet)
can have an affect on the level of circulating thyroid hormones inrats, thus carrying to an increase in the incidence of thyroid tu-
mours. The response of the US FDA in 1990 was to remove the
ErB lakes (salts), but not Erythrosine, of all foods, drugs and cos-
metics, in addition to remove ErB in cosmetics and externally ap-
plied drugs (EFSA, 2011).
However, ErB consumption exceeds its ADI by 2- to 6-fold in
some population (Dixit et al., 2011) and some studies describe
several toxic side effects: studied since the 1980’s, ErB has al-
ready been proven to be mutagenic by the Bacillus subtilis
multigene sporulation assay (Lakdawalla and Netrawali, 1988a)
and nonmutagenic by Ames/Salmonella test (Lakdawalla and
Netrawali, 1988b). Other studies demonstrated ErB toxicity by
different in vivo and in vitro assays: Furumiya and Mizutani
(2008) reported CYP3A4 (major phase I drug-metabolizing en-
zyme) and P-glycoprotein (major transporter of synthetic food
dyes) inhibition by ErB and other food dyes. In addition, ErB
inhibits both TNF–R–TNFa and CD40–CD154 protein–protein
interactions, which are responsible for tumor necrosis and effec-
tive immune responses, respectively (Ganesan et al., 2011). In
vivo studies of ErB in rats demonstrated toxic effects on sper-
matogenesis (Abdel Aziz et al., 1997) and pituitary perturba-
tions that may promote tumor formation due to the high
iodine content (Jennings et al., 1990a). Furthermore, DNA dam-
age was veriﬁed in rat glandular stomach, colon and urinary
bladder tissues just 3 h after a single high dose (200 mg kg1)
(Sasaki et al., 2002).
ErB (330 lM = 275.84 lg mL1) induced chromosome aberra-
tions in Syrian Hamster Embryo (SHE) cells in the presence of met-
abolic activation. The percentage of cells with polyploidy or
endoreduplication was enhanced by ErB also in the presence of
exogenous metabolic activation, suggesting that this food dye
could be potentially genotoxic to mammalian cells (Hagiwara
et al., 2006).
3450 F.M.D. Chequer et al. / Food and Chemical Toxicology 50 (2012) 3447–3451Mekkawy et al. (2000) treated male rats with ErB (with 0.08 and
0.4 g kg1 supplemented diet) for 30 days. Changes in mutagenic
activities were monitored by measuring chromosomal aberrations
of rat bone marrow, nucleic acids and total protein concentrations
of rat liver and brain. This study found that ErB induced chromo-
somal aberrations. Biochemical assays indicated a signiﬁcant in-
crease in the total protein concentration and nucleic acids in the
rat brain and liver by both doses. Results indicated that both ErB
doses exert mutagenic activity, being the highest dose more effec-
tive than the lower one.
Within this context, the present investigation used HepG2 cells
that are a human derived liver cell line to evaluate the genotoxicity
and mutagenicity of different ErB concentrations. The highest dose
used in these experiments (70.0 lg mL1) was deﬁned by the try-
pan-blue exclusion method. The HepG2 cells were treated with
0.1–100.0 lg mL1 ErB, and trypan-blue analysis was performed
after 4 and 20 h treatment (simulating the comet assay and
CBMN-Cyt assay, respectively). Only concentrations ranging from
0.1 to 70.0 lg mL1 ErB showed P80% cell viability after both
treatments and were chosen for the in vitro experiments. This
study is the ﬁrst to evaluate ErB using the CBMN-Cyt assay, which
provides advantages when compared to other cytogenetic meth-
ods: it is possible to evaluate mutagenic and cytostatic effects in
the same assay and to predict the DNA damage mechanism
involved.
Our results conﬁrm both the genotoxicity and mutagenicity of
this FDA-approved food dye at low and high concentrations. The
Tail Moment and Tail Intensity were statistically higher in the
experimental groups (50.0 and 70.0 lg mL1) than the vehicle con-
trol group, indicating the increase of DNA damage in the HepG2
cells after 4 h of exposure. In the CBMN-Cyt assay, all of the tested
concentrations, with the exception of 0.1 lg mL1, were sufﬁcient
to increase the MN frequencies.
By associating the CBMN-Cyt to the comet assay after ErB treat-
ment, these results also suggest the ErB damage mechanism in-
volved. The CBMN-Cyt detects both aneugenic and/or clastogenic
effects, while comet assay is often considered more sensitive and
detects DNA single strain breaks (He et al., 2000). Then, the posi-
tive results on six tested concentrations on CBMN-Cyt and the ab-
sence of this response on 0.1, 0.2, 2.0, 10.0 and 25.0 lg mL1
treatments on comet assay could suggest an aneugenic process
that resulted in permanent changes in the DNA structure. More-
over, the NPB and NBUD analyses (CBMN-Cyt assay) ensure that
the observation were not due to gene ampliﬁcation or chromo-
some rearrangements.
According to Mpountoukas et al. (2010), ErB decreased the Mi-
totic Index of human blood lymphocytes, which can mimic in vivo
metabolism, as HepG2 cells do, whereas the NDI values calculated
in the present study were not altered after ErB treatment. This dif-
ference is most likely due to the tested concentrations (1 mM–
0.8 mg mL1 versus maximum 70.0 lg mL1).
In conclusion, although being approved for use in the food, cos-
metic and pharmaceutical industries, ErB can pose health risks and
should be used with caution.Conﬂict of Interest
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